510(k) K210327
K210327 is an FDA 510(k) premarket notification submitted by W.H.P.M., Inc. for the device "First Sign Multi-Drug Test Dip Card, First Sign Multi-Drug Test Cup, First Sign Multi-Drug Screen Test Dip Card, First Sign Multi-Drug Screen Test Cup". The FDA issued a decision of Substantially Equivalent on August 12, 2021. The device falls under product code QBF (Test, Propoxyphene, Over The Counter), a Class II device regulated under 21 CFR 862.3700. W.H.P.M., Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 12, 2021
- Date Received
- February 4, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Test, Propoxyphene, Over The Counter
- Device Class
- Class II
- Regulation Number
- 862.3700
- Review Panel
- TX
- Submission Type
The propoxyphene test is an in vitro diagnostic test for the qualitative detection of propoxyphene in human urine. The test is intended for over-the-counter use as the first step in a two step process to provide consumers with information concerning the presence or absence of propoxyphene in a urine sample.